ShariaPortfolio’s Vertex Pharmaceuticals VRTX Stock Holding History

ShariaPortfolio’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,140	Closed	-$1.44M	–	45
2023 Q3	$1.44M	Buy	+4,140	New	+$1.45M	1.14%	20

Other funds holding VRTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ShariaPortfolio's VRTX Position: Q4 2023 in Review

ShariaPortfolio sold out of Vertex Pharmaceuticals (VRTX) in Q4 2023, closing a stake of 4,140 shares — an estimated $1.44M sold.

ShariaPortfolio first reported a position in VRTX in Q3 2023 and held it in 1 quarter. The position peaked at $1.44M in Q3 2023. 1,438 funds tracked by Wall St. Rank hold VRTX as of Q4 2023.

ShariaPortfolio reported no remaining Vertex Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
ShariaPortfolio sold 4,140 Vertex Pharmaceuticals shares in Q4 2023, an estimated $1.44M.
ShariaPortfolio first reported a position in Vertex Pharmaceuticals in Q3 2023 and held it in 1 quarter.
ShariaPortfolio's Vertex Pharmaceuticals position peaked at $1.44M in Q3 2023.
1,438 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2023.

Based on ShariaPortfolio's 13F filing for Q4 2023, filed 14 Feb 2024.